New Target and New Drug for Glioblastoma Identified
Medindia,
Mutation in the epidermal growth factor receptor (EGFR) is associated with decreased survival rates among patients with the…
Antibody Drug May Be Effective Against Broader Class of Brain Cancers
Technology Networks,
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell…
Penn study finds mutation driving deadlier brain tumours and potential therapy to stop it. ecancer
ecancer,
A poorly understood mutation in the brain cancer glioblastoma (GBM) is now being implicated for the first time as the driver of…
Ludwig-developed antibody drug for deadly brain cancer may have broader applications
The Medical News,
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell…